Beijing Tiantan hospital
Beijing, Beijing Municipality, 100070, China
Location status: Recruiting
NCT Number: NCT06527807
The objectives of this study are: (1) to describe the detailed clinical characteristics and prognosis of ASPP patients in order to explore the risk factors of ASPP, and to compare the short-term and long-term functional recovery outcomes between them and their controls; (2) to evaluate the risk of recurrent stroke, particularly during subsequent pregnancies, in ASPP patients; (3) to assess the short-term and long-term outcomes of their offsprings and their future development status.
This study is divided into three parts. The first part is a case-control study to explore the risk factors of ASPP and the predictors of the prognosis of ASPP patients. The second part is a cohort study to evaluate the impact of ASPP on the risk of recurrent stroke. The third part is a cohort study to assess the impact of ASPP on the short-term and long-term outcomes of their offsprings by comparing the offsprings of ASPP patients with the offsprings of non-ASPP participants.
Interested in participating?
Request InfoFemale
Observational
Beijing, Beijing Municipality, 100070, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
Time frame: At follow-up (assessed between July 2024 to October 2024)
The modified Ranking Scale (mRS) scores of ASPP and other comparison participants evaluated by specialists. The mRS scores range from 0 to 6, with higher scores indicating worse outcomes.
Time frame: At follow-up (assessed between July 2024 to October 2024)
Participants who suffer from recurrent stroke events confirmed by neuroimaging
Time frame: At 1 minutes, 5 minutes and 10 minutes after delivery
Apgar scores of newborns evaluated by specialists. Apgar scores range from 0 to 10, with higher scores indicating better outcomes. Apgar score 8-10 is considered as no asphyxia, 4-7 is considered as mild asphyxia, 0-3 is considered as severe asphyxia.
Time frame: At follow-up (assessed between July 2024 to October 2024)
Age & Stages Questionnaires, Third Edition (ASQ-3) scores of offsprings via online self-evaluation. ASQ-3 is divided into 5 subdomains. Scores of each subdomain range from 0 to 60, with higher scores indicating better outcomes.
Time frame: At discharge (assessed up to 5 days)
The modified Ranking Scale (mRS) scores of ASPP and other comparison participants evaluated by specialists. The mRS scores range from 0 to 6, with higher scores indicating worse outcomes.
Time frame: During subsequent pregnancies (assessed up to 5 days after the 6-week postpartum period of subsequent pregnancies)
Participants who suffer from stroke events during any subsequent pregnancy
Time frame: Before or at delivery
Dead fetus in the uterus at any trimester of pregnancy, or birth of a dead infant after 28+1 gestational weeks
Time frame: At follow-up (assessed between July 2024 to October 2024)
Offsprings requiring hospitalization due to diagnosed diseases within 15 years after birth, including neurological diseases (e.g. epilepsy, cerebral palsy), cardiovascular diseases (e.g. congenital heart disease), gastrointestinal diseases (e.g. necrotizing enterocolitis), respiratory diseases (e.g. allergic asthma), urological diseases (e.g. hypospadias), hematological and immunological diseases and other major diseases
Time frame: Between admission and discharge (assessed up to 5 days)
Time span of hospitalization as a resulting from stroke treatment
Contact information is provided by the study sponsor or research team.
Zhongji Zhang, MD
CONTACT
Zihan Yin, MD
CONTACT
Beijing Tiantan Hospital
Other
Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium: A Retrospective, Observational, Nationwide, Multicenter Study
Acronym: ASPP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00009243
Brain Disease, Brain Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06615973
Brain Disease, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07738978
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Cleveland, Ohio, United States
View Trial DetailsNCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial Details